Chinedu Iroka
Social Member
Oxford University’s coronavirus vaccine opens for clinical trial on humans
ChAdOx1 nCoV-19, the COVID-19 vaccine developed by Oxford, is based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein.
www.thehindu.com